by Hansraj Agrawal | Aug 24, 2024 | Share Market
Last Updated : Aug 24 2024 | 4:31 PM IST
Ashoka Buildcon informed that it has emerged as the lowest bidder (L-1) for a project worth Rs 478 crore awarded by Mumbai Metropolitan Region Development Authority (MMRDA).
The said project includes design and construction of elevated road from Kalyanmurbad Road (Palms Water Resort) to Badlapur Road (Jagdish Dughdhalaya) to Pune Link Road parallel to Waldhuni River crossing over Karjat- Kasara Railway line including slip road.
The company has quoted bid price of Rs 478 crore and it will be executed within 36 months including monsoon period.
Ashoka Buildcon is engaged in construction & maintenance of roads and supporting services to land support-operation of toll roads.
The company has reported a standalone net profit of Rs 40.8 crore in Q1 FY25, which is significantly higher as compared with the PAT of Rs 16.4 crore in Q1 FY24. Total income rose by 22% year-over-year (YoY) to Rs 1,900.8 crore during the period under review.
The scrip declined 1.13% to settle at Rs 232.40 on Friday, 23 August 2024.
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 24 2024 | 4:03 PM IST
Source link
by Hansraj Agrawal | Aug 24, 2024 | Share Market
Last Updated : Aug 24 2024 | 3:16 PM IST
Sales rise 0.77% to Rs 131.00 crore
Net profit of Rathi Industries reported to Rs 1.25 crore in the quarter ended June 2024 as against net loss of Rs 27.49 crore during the previous quarter ended June 2023. Sales rose 0.77% to Rs 131.00 crore in the quarter ended June 2024 as against Rs 130.00 crore during the previous quarter ended June 2023.
ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales131.00130.00 1 OPM %1.15-1.28 –PBDT1.50-1.67 LP PBT1.50-1.67 LP NP1.25-27.49 LP
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 24 2024 | 3:01 PM IST
Source link
by Hansraj Agrawal | Aug 24, 2024 | Share Market
Last Updated : Aug 24 2024 | 3:16 PM IST
Sales rise 83.31% to Rs 110.61 crore
Net profit of Lohia Securities rose 87.56% to Rs 8.44 crore in the quarter ended June 2024 as against Rs 4.50 crore during the previous quarter ended June 2023. Sales rose 83.31% to Rs 110.61 crore in the quarter ended June 2024 as against Rs 60.34 crore during the previous quarter ended June 2023.
ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales110.6160.34 83 OPM %7.6311.87 –PBDT8.446.24 35 PBT8.446.03 40 NP8.444.50 88
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 24 2024 | 3:01 PM IST
Source link
by Hansraj Agrawal | Aug 24, 2024 | Share Market
Last Updated : Aug 24 2024 | 3:16 PM IST
Sales rise 23.44% to Rs 1.58 crore
Net loss of Aashrit Capital reported to Rs 0.29 crore in the quarter ended June 2024 as against net profit of Rs 0.26 crore during the previous quarter ended June 2023. Sales rose 23.44% to Rs 1.58 crore in the quarter ended June 2024 as against Rs 1.28 crore during the previous quarter ended June 2023.
ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales1.581.28 23 OPM %-18.3535.16 –PBDT-0.290.45 PL PBT-0.290.42 PL NP-0.290.26 PL
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 24 2024 | 3:01 PM IST
Source link
by Hansraj Agrawal | Aug 24, 2024 | Share Market
Last Updated : Aug 24 2024 | 3:16 PM IST
Reported sales nil
Net Loss of SNS Properties & Leasing reported to Rs 0.02 crore in the quarter ended June 2024 as against net loss of Rs 0.01 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 24 2024 | 3:00 PM IST
Source link
by Hansraj Agrawal | Aug 24, 2024 | Share Market
Last Updated : Aug 24 2024 | 3:16 PM IST
Dr Reddy’s Laboratories said that the US drug regulator has issued Form 483, with three observations after inspecting its Andhra Pradesh manufacturing facility.
According to the exchange filing the United States Food & Drug Administration (USFDA) has completed a product-specific Pre-Approval Inspection (PAI) at its formulations manufacturing facility in Srikakulam, Andhra Pradesh.
The said inspection was conducted from 19 August 2024 to 23 August 2024. Following the inspection, the USFDA has issued a Form 483 with three observations. The company has committed to addressing these observations within the stipulated timeline.
Dr Reddy’s Labs is engaged in providing medicines. The firm operates in three segments: global generics, pharmaceutical services and active ingredients (PSAI) and proprietary products.
The companys consolidated net profit shed marginally to Rs 1,392.40 crore in Q1 FY25 as against 1,405 crore posted in Q1 FY24. However revenue from operations jumped 13.9% YoY to Rs 7,672.70 crore in Q1 FY25.
The scrip shed 0.28% to settle at Rs 6,953.20 on Friday, 23 August 2024.
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 24 2024 | 2:50 PM IST
Source link
